In spite of the comprehensive investigations of Goldin (1982) and Brock (1983) The toxicity included marked bone marrow depression, one septic death during neutropenia and two episodes of transient neurologic disorders during IFO infusion. ]FO is active in recurrent Ewing's sarcoma and is wee tolerated as continuous infusion over 5 days when administered with mesna uroproteetion and forced diuresis over 7 days. The response rate was not increased when IFO was combined with DDP, however, longer remissions were seen in pts. who had received the combination of both drugs.
